Inhalation therapy with high doses of nitric oxide in a comorbid patient with COVID-19: A clinical case
N. O. Kamenshchikov,
M. S. Kuznetsov,
M. L. Diakova,
Yu. K. Podoksenov,
T. P. Kalashnikova,
M. A. Tyo,
E. A. Churilina,
B. N. Kozlov https://doi.org/10.29001/2073-8552-2022-37-4-180-187
Abstract
The article describes a clinical case of inhalation therapy with high doses of nitric oxide (NO) in a comorbid patient with a severe course of COVID-19. An air stream containing NO was generated using the PLAZON device. High-dose NO inhalation therapy was administered as a life-saving option due to the lack of effect from treatment delivered in accordance with the current national clinical guidelines for the treatment of COVID-19. The safety and clinical efficacy of the technique was demonstrated.
About the Authors
N. O. Kamenshchikov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
Nikolay O. Kamenshchikov, Cand. Sci. (Med.), Intensive Care Physician, Department of Anesthesiology and Intensive Care
111a, Kievskaya str., Tomsk, 634012
M. S. Kuznetsov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
Mikhail S. Kuznetsov, Cand. Sci. (Med.), Senior Research Scientist, Department of Cardiovascular Surgery
111a, Kievskaya str., Tomsk, 634012
M. L. Diakova
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
Maria L. Diakova, Cand. Sci. (Med.), Research Scientist, Department of Cardiovascular Surgery
111a, Kievskaya str., Tomsk, 634012
Yu. K. Podoksenov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
Yury K. Podoksenov, Dr. Sci. (Med.), Leading Research Scientist, Department of Cardiovascular Surgery
111a, Kievskaya str., Tomsk, 634012
T. P. Kalashnikova
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
Tatiana P. Kalashnikova, Cand. Sci. (Med.), Clinical Pharmacologist
111a, Kievskaya str., Tomsk, 634012
M. A. Tyo
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
Mark A. Tyo, Anesthesiology Resident, Department of Anesthesiology and Intensive Care
111a, Kievskaya str., Tomsk, 634012
E. A. Churilina
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
Elena A. Churilina, Intensive Care Physician, Department of Anesthesiology and Intensive Care
111a, Kievskaya str., Tomsk, 634012
B. N. Kozlov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
Boris N. Kozlov, Dr. Sci. (Med.), Head of Department of Cardiovascular Surgery
111a, Kievskaya str., Tomsk, 634012
References
1. Ichinose F., Roberts J.D. Jr., Zapol W.M. Inhaled nitric oxide: A selective pulmonary vasodilator: Current uses and therapeutic potential. Circulation. 2004;109(25):3106–3111. DOI: 10.1161/01.CIR.0000134595.80170.62.
2. Mehta D.R., Ashkar A.A., Mossman K.L. The Nitric Oxide Pathway Provides Innate Antiviral Protection in Conjunction with the Type I Interferon Pathway in Fibroblasts. PLoS One. 2012;7(2):e31688. DOI: 10.1371/journal.pone.0031688.
3. Åkerström S., Gunalan V., Keng C.T., Tan Y.-J., Mirazimi A. Dual effect of nitric oxide on SARS-CoV replication: Viral RNA production and palmitoylation of the S protein are affected. Virology. 2009;395(1):1–9. DOI: 10.1016/j.virol.2009.09.007.
4. Xu W., Zheng S., Dweik R.A., Erzurum S.C. Role of epithelial nitric oxide in airway viral infection. Free Radic. Biol. Med. 2006;41(1):19–28. DOI: 10.1016/j.freeradbiomed.2006.01.037.
5. Klingstrom J., Åkerström S., Hardestam J., Stoltz M., Simon M., Falk K.I. et al. Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virions. Eur. J. Immunol. 2006;36(10):2649–2657. DOI: 10.1002/eji.200535587.
6. Jung K., Gurnani A., Renukaradhya G.J., Saif L.J. Nitric oxide is elicited and inhibits viral replication in pigs infected with porcine respiratory coronavirus but not porcine reproductive and respiratory syndrome virus. Vet. Immunol. Immunopathol. 2010;136(3-4):335–339. DOI: 10.1016/j.vetimm.2010.03.022.
7. Uehara E.U., de Stefano Shida B., de Brito C.A. The role of nitric oxide in immune responses against viruses is beyond microbicidal activity. Inflamm. Res. 2015;64(11):845–852. DOI: 10.1007/s00011-015-0857-2.
8. Vanin A.F. Dinitrosyl iron complexes with thiolate ligands: Physico-chemistry, biochemistry and physiology. Nitric. Oxide. 2009;21(1):1–13. DOI: 10.1016/j.niox.2009.03.005.
9. Vanin A.F. Dinitrosyl Iron сomplexes as a “working form” of nitric oxide in living organisms. Cambridge, UK: Cambridge Scholars Publ.; 2019:276.
10. Vanin A.F. Dinitrosyl iron complexes with thiol-containing ligands can suppress viral infections as donors of the nitrosonium cation (hypothesis). Biophysics (Oxf.). 2020;65(4):698–702. DOI: 10.1134/ S0006350920040260.
11. Deppisch C., Herrmann G., Graepler-Mainka U., Wirtz H., Heyder S., Engel C. et al. Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: A phase I clinical study. Infection. 2016;44(4):513–520. DOI: 10.1007/s15010-0160879-x.
12. Miller C., McMullin B., Ghaffari A., Stenzler A., Pick N., Roscoe D. et al. Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure. Nitric. Oxide. 2009;20(1):16–23. DOI: 10.1016/j.niox.2008.08.002.
13. Ma L., Wang W., Le Grange J.M., Wang X., Du S. Li C. et al. Coinfection of SARS-CoV-2 and other respiratory pathogens. Infect. Drug Resist. 2020;13:3045–3053. DOI: 10.2147/IDR.S267238.
14. Kim D., Quinn J., Pinsky B., Shah N.H., Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. 2020;323(20):2085–2086. DOI: 10.1001/jama.2020.6266.
15. Kobayashi J., Murata I. Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome. Ann. Intensiv. Care. 2020;10(1):61. DOI: 10.1186/s13613-020-00681-9.
16. Kamenshchikov N.O., Berra L., Carroll R.W. Therapeutic effects of inhaled nitric oxide therapy in COVID-19 patients. Biomedicines. 2022;10(2):369. DOI: 10.3390/biomedicines10020369.
17. Kamenshchikov N.O., Kozlov B.N., Dish A.Y., Podoksenov Y.K., Anfinogenova N.D., Boshchenko A.A. et al. Abstract 11986: A Safety Study of Intermittent versus Continuous Inhaled NO Therapy in Spontaneously Breathing COVID-19 Patients: A Randomized Controlled Trial. Circulation. 2021;144(1):A11986.
18. McMahon T.J., Doctor A. Extrapulmonary effects of inhaled nitric oxide: Role of reversible S-nitrosylation of erythrocytic hemoglobin. Proc. Am. Thorac. Soc. 2006;3(2):153–160. DOI: 10.1513/pats.200507-066BG.
Review
For citations:
Kamenshchikov N.O., Kuznetsov M.S., Diakova M.L., Podoksenov Yu.K., Kalashnikova T.P., Tyo M.A., Churilina E.A., Kozlov B.N. Inhalation therapy with high doses of nitric oxide in a comorbid patient with COVID-19: A clinical case. Siberian Journal of Clinical and Experimental Medicine. 2022;37(4):180-187. (In Russ.) https://doi.org/10.29001/2073-8552-2022-37-4-180-187
Views:
394
.png)
Email this article 